| Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model X Xin, M Majumder, GV Girish, V Mohindra, T Maruyama, PK Lala Laboratory investigation 92 (8), 1115-1128, 2012 | 163 | 2012 |
| Pharmacogenomics of anti-TB drugs-related hepatotoxicity PD Roy, M Majumder, B Roy Pharmacogenomics 9 (3), 311-321, 2008 | 146 | 2008 |
| The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis E Tutunea-Fatan, M Majumder, X Xin, PK Lala Molecular cancer 14, 1-16, 2015 | 134 | 2015 |
| COX-2 induces breast cancer stem cells via EP4/PI3K/AKT/NOTCH/WNT axis M Majumder, X Xin, L Liu, E Tutunea-Fatan, M Rodriguez-Torres, ... Stem Cells 34 (9), 2290-2305, 2016 | 132 | 2016 |
| Prostaglandin E2 receptor EP 4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem‐like cell functions M Majumder, X Xin, L Liu, GV Girish, PK Lala Cancer science 105 (9), 1142-1151, 2014 | 96 | 2014 |
| Increased Risk of Oral Leukoplakia and Cancer Among Mixed Tobacco Users Carrying XRCC1 Variant Haplotypes and Cancer Among Smokers Carrying Two Risk Genotypes: One on�… M Majumder, N Sikdar, RR Paul, B Roy Cancer Epidemiology Biomarkers & Prevention 14 (9), 2106-2112, 2005 | 84 | 2005 |
| EP4 as a therapeutic target for aggressive human breast cancer M Majumder, P Nandi, A Omar, KC Ugwuagbo, PK Lala International journal of molecular sciences 19 (4), 1019, 2018 | 83 | 2018 |
| Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators M Majumder, N Sikdar, S Ghosh, B Roy International journal of cancer 120 (10), 2148-2156, 2007 | 83 | 2007 |
| Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer C Misra, M Majumder, S Bajaj, S Ghosh, B Roy, S Roychoudhury Molecular Carcinogenesis: Published in cooperation with the University of�…, 2009 | 82 | 2009 |
| PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells P Nandi, GV Girish, M Majumder, X Xin, E Tutunea-Fatan, PK Lala BMC cancer 17, 1-17, 2017 | 79 | 2017 |
| COX-2 elevates oncogenic miR-526b in breast cancer by EP4 activation M Majumder, E Landman, L Liu, D Hess, PK Lala Molecular Cancer Research 13 (6), 1022-1033, 2015 | 78 | 2015 |
| Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer PK Lala, P Nandi, M Majumder Cancer Metastasis Rev, 2018 | 76 | 2018 |
| COX-2 induces oncogenic micro RNA miR655 in human breast cancer M Majumder, L Dunn, L Liu, A Hasan, K Vincent, M Brackstone, D Hess, ... Scientific reports 8 (1), 327, 2018 | 72 | 2018 |
| Mir526b and Mir655 promote tumour associated angiogenesis and lymphangiogenesis in breast cancer S Hunter, B Nault, KC Ugwuagbo, S Maiti, M Majumder Cancers 11 (7), 938, 2019 | 69 | 2019 |
| Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and Autosomal GSTP1 locus S Datta, M Majumder, NK Biswas, N Sikdar, B Roy Cancer 110 (9), 1991-1999, 2007 | 58 | 2007 |
| miR526b and miR655 induce oxidative stress in breast cancer B Shin, R Feser, B Nault, S Hunter, S Maiti, KC Ugwuagbo, M Majumder International Journal of Molecular Sciences 20 (16), 4039, 2019 | 40 | 2019 |
| Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN M Majumder, E Tutunea-Fatan, X Xin, M Rodriguez-Torres, ... PLoS One 7 (4), e35094, 2012 | 33 | 2012 |
| Chemically induced hypoxia enhances miRNA functions in breast cancer E Gervin, B Shin, R Opperman, M Cullen, R Feser, S Maiti, M Majumder Cancers 12 (8), 2008, 2020 | 30 | 2020 |
| Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells J Tordjman, M Majumder, M Amiri, A Hasan, D Hess, PK Lala BMC cancer 19, 1-16, 2019 | 29 | 2019 |
| Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis GADP Linares, RM Opperman, M Majumder, PK Lala Cancers 13 (5), 942, 2021 | 24 | 2021 |
Peeyush Laladepartment of anatomy and cell biology, university of western ontarioVerified email at uwo.ca
